Advanced Search

 

Study ID Status Title Patient Level Data
SAS40028 Completed An Open-Label, 12-Week Study to Evaluate the Effects of a Corticosteroid-Sparing Dose of Salmeterol/Fluticasone Propionate Combination Product 50/100mcg twice daily Via the DISKUS Inhaler on Airway Inflammation, Airway Remodeling, and Bronchial Hyperresponsiveness in Adults with Persistent Asthma Study Listed on ClinicalStudyDataRequest.com
SAS40036 Completed A multicenter, randomized, double-blind, double-dummy, parallel group, 16-week comparison of asthma control in adolescent and adults receiving either fluticasone propionate/salmeterol Diskus combination product 100/50mcg twice daily, fluticasone propionate Diskus 100mcg twice daily, salmeterol xinafoate 50mcg twice daily, or oral montelukast 10mg every day Study Listed on ClinicalStudyDataRequest.com
SAS40037 Completed A multicenter, randomized, double-blind, double-dummy, parallel group, 16-week comparison of asthma control in adolescents and adults receiving either fluticasone propionate/salmeterol Diskus combination product 100/50mcg twice daily, fluticasone propionate Diskus 100mcg twice daily, salmeterol xinafoate 50mcg twice daily, or oral montelukast 10mg every day Study Listed on ClinicalStudyDataRequest.com
SAS40066 Completed A Randomized, Open Label, Pilot Crossover Trial, Assessing Patient Preference for Efficacy of Advair Diskus 100/50 (Fluticasone Propionate 100mcg and Salmeterol 50mcg Combination Product 100/50mcg twice daily) and Singulair (Montelukast 10mg every day) in Subjects>15 years of Age with Persistent Asthma Study Listed on ClinicalStudyDataRequest.com
SB 480848/035 Completed A Study to Evaluate the Effect of Repeat Oral Doses of Darapladib on Cardiac Conduction as Compared to Placebo and a Single Oral Dose of Moxifloxacin Study Listed on ClinicalStudyDataRequest.com
SB020001 Completed A Four-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-group, Multi-Center Study of VENTOLIN™ (albuterol) HFA MDI delivered with facemask and two different holding chambers in Subjects aged 24 to <48 months with asthma symptoms (i.e. wheeze, cough, dyspnea or chest tightness) or consistent with asthma or obstructive airway disease or bronchospasm. Study Listed on ClinicalStudyDataRequest.com
SB030001 Completed A Four-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-group, Multi-Center Study of VENTOLIN™ HFA MDI delivered TID with facemask and valved holding chamber Aerochamber Plus in subjects birth to <24 months in age with symptoms of bronchospasm (i.e. wheeze, cough, dyspnea or chest tightness) consistent with obstructive airways disease. Study Listed on ClinicalStudyDataRequest.com
SB030002 Completed A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively with a valved holding chamber and an attached facemask in subjects between birth to 23 months of age with acute wheezing due to obstructive airways disease Study Listed on ClinicalStudyDataRequest.com
SB030003 Completed An Open-Label, Multi-Center Study to Evaluate the Performance and Patient Satisfaction of Albuterol HFA with Counter in Asthma or COPD Subjects at Least 4 Years of Age. Study Listed on ClinicalStudyDataRequest.com
SB-480848/026 Completed An international, multicenter, randomized, placebo controlled, parallel-group, 1 year treatment, integrated biomarkers and imaging study in subjects with angiographically documented coronary artery disease (CHD) to examine the effects of the novel lipoprotein-associated phospholipase A2 (Lp-PLA2) in Study Listed on ClinicalStudyDataRequest.com
SB-714703/003 Completed An open, randomised, multi-centre dose-ranging phase II study to evaluate LAPDAP in combination with three different doses of artesunate.
SBM20002 Completed A single centre, randomised, double-blind, placebo-controlled, crossover, pilot study to determine the efficacy and safety of 400 µg and 200 µg doses of Ventolin ™ salbutamol inhaler versus placebo for the treatment of smoking related cough. Study Listed on ClinicalStudyDataRequest.com
SBM40003 Completed A single centre, randomised, double blind, double dummy, cross-over study to measure the topical and systemic effects of Salbutamol delivered by the Turbuhaler inhaler compared with the Diskus dry powder inhaler at high and low flow rates in adult patients with reversible obstructive airways disease. Study Listed on ClinicalStudyDataRequest.com
SCA100223 Completed A Multicenter, Double-Blind, Placebo-Controlled, Fixed-Dose, 8-Week Evaluation of the Efficacy and Safety of Lamotrigine in the Treatment of Depression in Patients with Type II Bipolar Disorder Study Listed on ClinicalStudyDataRequest.com
SCA102833 Completed The Evaluation of Lamictal as an Add-on Treatment for Bipolar I Disorder in Children and Adolescents, 10 to 17 Years of Age Study Listed on ClinicalStudyDataRequest.com
SCA10908 Completed A randomised, partially blinded, parallel group study to investigate the potential pharmacokinetic interaction between lamotrigine and olanzapine in healthy, non-smoking, male volunteers. Study Listed on ClinicalStudyDataRequest.com
SCA10910 Completed A randomised, partially blinded, parallel group study to investigate the potential pharmacokinetic interaction between lamotrigine and oxcarbazepine in healthy, non-smoking, male volunteers. Study Listed on ClinicalStudyDataRequest.com
SCA30924 Completed Double blind placebo controlled study of lamictal in acute bipolar depression Study Listed on ClinicalStudyDataRequest.com
SCA30926 Completed A Multi-Center, Double blind, Placebo-controlled, Randomized, Parallel Group Evaluation of the Efficacy of a Flexible Dose of Lamotrigine versus Placebo As Add-On Therapy In Schizophrenia Study Listed on ClinicalStudyDataRequest.com
SCA40910 Completed A Multicenter, Double-Blind, Placebo-Controlled, Fixed-Dose Evaluation of the Safety, Efficacy, and Tolerability of LAMICTAL (Lamotrigine) in the Treatment of a Major Depressive Episode in Patients with Type I Bipolar Disorder Study Listed on ClinicalStudyDataRequest.com
SCA40917 Completed Lamictal for use in treatment of Bipolar Disorder In Adults. A Practical Clinical Assessment of Tolerability and Clinical Effectiveness. Study Listed on ClinicalStudyDataRequest.com
SCAA4001 Completed A Double-blind, Double-dummy, Parallel-group Comparison of Lamotrigine and Divalproex Sodium Initial Monotherapy in Patients with Epilepsy Study Listed on ClinicalStudyDataRequest.com
SCAB2003 Completed A Multicenter, Double-blind, Placebo-controlled, Randomized, Fixed-dose Evaluation of the Safety and Efficacy of Lamotrigine in the Long-term Prevention of Relapse and Recurrence of Depression and/or Mania in Subjects with Bipolar I Disorder Study Listed on ClinicalStudyDataRequest.com
SCO100250 Completed See Detailed Description Study Listed on ClinicalStudyDataRequest.com
SCO100648 Completed Clinical Evaluation of GW815SF for Chronic Obstructive Pulmonary Disease (Chronic Bronchitis, Emphysema)“ A Long-term Treatment Study of GW815SF50/500µg in Chronic Obstructive Pulmonary Disease -

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.